239 related articles for article (PubMed ID: 23171444)
1. IL-12 based gene therapy in veterinary medicine.
Pavlin D; Cemazar M; Sersa G; Tozon N
J Transl Med; 2012 Nov; 10():234. PubMed ID: 23171444
[TBL] [Abstract][Full Text] [Related]
2. Cancer electrogene therapy with interleukin-12.
Cemazar M; Jarm T; Sersa G
Curr Gene Ther; 2010 Aug; 10(4):300-11. PubMed ID: 20560875
[TBL] [Abstract][Full Text] [Related]
3. Local and systemic antitumor effect of intratumoral and peritumoral IL-12 electrogene therapy on murine sarcoma.
Pavlin D; Cemazar M; Kamensek U; Tozon N; Pogacnik A; Sersa G
Cancer Biol Ther; 2009 Nov; 8(22):2114-22. PubMed ID: 19755854
[TBL] [Abstract][Full Text] [Related]
4. Electroporation-mediated IL-12 gene therapy in a transplantable canine cancer model.
Chuang TF; Lee SC; Liao KW; Hsiao YW; Lo CH; Chiang BL; Lin XZ; Tao MH; Chu RM
Int J Cancer; 2009 Aug; 125(3):698-707. PubMed ID: 19431145
[TBL] [Abstract][Full Text] [Related]
5. Double-blind placebo-controlled study with interleukin-18 and interleukin-12-encoding plasmid DNA shows antitumor effect in metastatic melanoma in gray horses.
Müller J; Feige K; Wunderlin P; Hödl A; Meli ML; Seltenhammer M; Grest P; Nicolson L; Schelling C; Heinzerling LM
J Immunother; 2011 Jan; 34(1):58-64. PubMed ID: 21150713
[TBL] [Abstract][Full Text] [Related]
6. A phase I trial of hyperthermia-induced interleukin-12 gene therapy in spontaneously arising feline soft tissue sarcomas.
Siddiqui F; Li CY; Larue SM; Poulson JM; Avery PR; Pruitt AF; Zhang X; Ullrich RL; Thrall DE; Dewhirst MW; Hauck ML
Mol Cancer Ther; 2007 Jan; 6(1):380-9. PubMed ID: 17237297
[TBL] [Abstract][Full Text] [Related]
7. Electroporation gene therapy preclinical and clinical trials for melanoma.
Heller LC; Heller R
Curr Gene Ther; 2010 Aug; 10(4):312-7. PubMed ID: 20557286
[TBL] [Abstract][Full Text] [Related]
8. Regression of tumor growth and induction of long-term antitumor memory by interleukin 12 electro-gene therapy.
Li S; Zhang X; Xia X
J Natl Cancer Inst; 2002 May; 94(10):762-8. PubMed ID: 12011227
[TBL] [Abstract][Full Text] [Related]
9. IL-12 gene therapy using an electrically mediated nonviral approach reduces metastatic growth of melanoma.
Lucas ML; Heller R
DNA Cell Biol; 2003 Dec; 22(12):755-63. PubMed ID: 14683586
[TBL] [Abstract][Full Text] [Related]
10. Gene Electrotransfer of Canine Interleukin 12 into Canine Melanoma Cell Lines.
Lampreht U; Kamensek U; Stimac M; Sersa G; Tozon N; Bosnjak M; Brozic A; de Sá Oliveira GG; Nakagawa T; Saeki K; Cemazar M
J Membr Biol; 2015 Oct; 248(5):909-17. PubMed ID: 25840833
[TBL] [Abstract][Full Text] [Related]
11. Intratumoral bleomycin and IL-12 electrochemogenetherapy for treating head and neck tumors in dogs.
Cutrera J; Torrero M; Shiomitsu K; Mauldin N; Li S
Methods Mol Biol; 2008; 423():319-25. PubMed ID: 18370210
[TBL] [Abstract][Full Text] [Related]
12. Intratumoral delivery of interleukin 12 expression plasmids with in vivo electroporation is effective for colon and renal cancer.
Tamura T; Nishi T; Goto T; Takeshima H; Dev SB; Ushio Y; Sakata T
Hum Gene Ther; 2001 Jul; 12(10):1265-76. PubMed ID: 11440620
[TBL] [Abstract][Full Text] [Related]
13. Phase I trial of interleukin-12 plasmid electroporation in patients with metastatic melanoma.
Daud AI; DeConti RC; Andrews S; Urbas P; Riker AI; Sondak VK; Munster PN; Sullivan DM; Ugen KE; Messina JL; Heller R
J Clin Oncol; 2008 Dec; 26(36):5896-903. PubMed ID: 19029422
[TBL] [Abstract][Full Text] [Related]
14. Plasmid IL-12 electroporation in melanoma.
Cha E; Daud A
Hum Vaccin Immunother; 2012 Nov; 8(11):1734-8. PubMed ID: 23151447
[TBL] [Abstract][Full Text] [Related]
15. Improving therapeutic efficacy of IL-12 intratumoral gene electrotransfer through novel plasmid design and modified parameters.
Burkart C; Mukhopadhyay A; Shirley SA; Connolly RJ; Wright JH; Bahrami A; Campbell JS; Pierce RH; Canton DA
Gene Ther; 2018 Apr; 25(2):93-103. PubMed ID: 29523878
[TBL] [Abstract][Full Text] [Related]
16. Candidate genes associated with tumor regression mediated by intratumoral IL-12 electroporation gene therapy.
Li S; Xia X; Mellieon FM; Liu J; Steele S
Mol Ther; 2004 Mar; 9(3):347-54. PubMed ID: 15006601
[TBL] [Abstract][Full Text] [Related]
17. Tumor regression of human and murine melanoma after intratumoral injection of IL-12-encoding plasmid DNA in mice.
Heinzerling L; Dummer R; Pavlovic J; Schultz J; Burg G; Moelling K
Exp Dermatol; 2002 Jun; 11(3):232-40. PubMed ID: 12102662
[TBL] [Abstract][Full Text] [Related]
18. Radiosensitizing effect of intratumoral interleukin-12 gene electrotransfer in murine sarcoma.
Sedlar A; Kranjc S; Dolinsek T; Cemazar M; Coer A; Sersa G
BMC Cancer; 2013 Jan; 13():38. PubMed ID: 23360213
[TBL] [Abstract][Full Text] [Related]
19. IL-12 plasmid delivery by in vivo electroporation for the successful treatment of established subcutaneous B16.F10 melanoma.
Lucas ML; Heller L; Coppola D; Heller R
Mol Ther; 2002 Jun; 5(6):668-75. PubMed ID: 12027550
[TBL] [Abstract][Full Text] [Related]
20. Electrochemo-gene therapy of cancer: intratumoral delivery of interleukin-12 gene and bleomycin synergistically induced therapeutic immunity and suppressed subcutaneous and metastatic melanomas in mice.
Kishida T; Asada H; Itokawa Y; Yasutomi K; Shin-Ya M; Gojo S; Cui FD; Ueda Y; Yamagishi H; Imanishi J; Mazda O
Mol Ther; 2003 Nov; 8(5):738-45. PubMed ID: 14599806
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
